Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures

IMPORTANCE: Antiseizure medication (ASM) treatment duration for acute symptomatic neonatal seizures is variable. A randomized clinical trial of phenobarbital compared with placebo after resolution of acute symptomatic seizures closed early owing to low enrollment. OBJECTIVE: To assess whether ASM di...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA Neurol
Hauptverfasser: Glass, Hannah C., Soul, Janet S., Chang, Taeun, Wusthoff, Courtney J., Chu, Catherine J., Massey, Shavonne L., Abend, Nicholas S., Lemmon, Monica, Thomas, Cameron, Numis, Adam L., Guillet, Ronnie, Sturza, Julie, McNamara, Nancy A., Rogers, Elizabeth E., Franck, Linda S., McCulloch, Charles E., Shellhaas, Renée A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Medical Association 2021
Schlagworte:
Original Investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8145161/
https://ncbi.nlm.nih.gov/pubmed/34028496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2021.1437
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge